Key Insights

Highlights

Treatment Research

6 treatments under study, led by Obtaining Dry Blood Spots From Healthy Children Aged 8 Days 7 Years

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT05910151Unknown

Selective Screening of Children for Hereditary Metabolic Diseases by Tandem Mass Spectrometry in Kazakhstan

Showing all 1 trials

Research Network

Common Treatments

  • Obtaining Dry Blood Spots From Healthy Children Aged 8 Days 7 Years1
  • Obtaining Dry Blood Spots From Highrisk Childrens Aged 8 18 Years1
  • Obtaining Dry Blood Spots From Healthy Children Aged 818 Years1
  • Obtaining Dry Blood Spots From Highrisk Childrens Aged 8 Days 7 Years1
  • Obtaining Dry Blood Spots From Highrisk Newborns Aged 17 Days1

Active Sponsors

  • West Kazakhstan Medical University1

Top Investigators

Related Conditions

  • Propionicmethylmalonic Acidemias1
  • Betaketothiolase Deficiency1
  • Citrullinemia1
  • Glutaric Acidemia Type Ii1
  • 3methylcrotonylcoa Carboxylase Deficiency1

Activity Timeline